UNSPSC 51143200: Anti abuse drugs

This classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.

UNSPSC 51143200 Anti abuse drugs (Class) encompasses naloxone and drug deactivation systems that state and local governments procure to support community health and substance abuse intervention initiatives. Recent solicitations show that issuing bodies are acquiring these products through competitive bidding processes, typically in quantities measured in hundreds to thousands of units annually with recurring delivery schedules. The code does not appear to reflect the broader scope of substance abuse treatment services—the Orange County procurement for DEJ and Offender Treatment Programs appears mistagged to this code, as it solicits counseling and educational training rather than pharmaceutical products or systems. County health departments represent the primary issuing body type active under this code, with procurement structured around fixed-term contracts (commonly two to three years) that include renewal options and specific insurance requirements.

Seminole County, Florida recently issued IFB60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Texas Health and Human Services Commission issued a separate RFI in April 2026 exploring direct-to-manufacturer prescription programs, though that inquiry targets pharmacy benefit management and contracting architecture rather than emergency response pharmaceuticals. Florida represents the most recent confirmed activity under the code; the source does not support sufficient geographic spread to characterize activity across multiple states or regions.